<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="183">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05158764</url>
  </required_header>
  <id_info>
    <org_study_id>ID RCB : 2021-A01874-37</org_study_id>
    <nct_id>NCT05158764</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of URGOBD001 Compression System</brief_title>
  <acronym>FUTURE</acronym>
  <official_title>Evaluation of the Efficacy and Safety of the New URGO BD001 Compression System Versus a Reference Compression in the Local Treatment of Venous or Mixed Predominantly Venous Leg Ulcers: a Prospective Open-label RCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires URGO</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires URGO</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the efficacy (wound epithelialization and time to closure) and safety&#xD;
      (emergence and nature of adverse event) of the new URGO BD001 compression system versus a&#xD;
      reference compression in the local treatment of venous or mixed predominantly venous leg&#xD;
      ulcers: prospective multicenter, randomized controlled, open-label clinical study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, controlled, open-label, multicenter clinical trial&#xD;
      conducted in patients with a leg ulcer of venous or mixed predominantly venous origin of&#xD;
      stage C6 / C6r of the CEAP classification.&#xD;
&#xD;
      This study is carried out in around 55 French investigational centers. A total of 178&#xD;
      patients meeting the eligibility criteria will be included. The patients will be followed for&#xD;
      12 weeks and a total of 5 clinical evaluations will be carried out by the investigating&#xD;
      centers.&#xD;
&#xD;
      A planimetric survey of the studied VLU is carried out during the initial assessment of the&#xD;
      wound (Day 0) and at each assessment provided for in the protocol (Week 2, Week 4, Week 8 and&#xD;
      Week 12).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete closure of the Venous Leg Ulcer (VLU)</measure>
    <time_frame>12-week treament period</time_frame>
    <description>Complete closure of the leg ulcer is defined by 100% re-epithelialization of the Venous Leg Ulcer (VLU)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to complete closure of the Venous Leg Ulcer (VLU)</measure>
    <time_frame>12-week treament period</time_frame>
    <description>Time to complete closure of the Venous Leg Ulcer (VLU) is defined as the time from inclusion to the date of complete closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety analysis</measure>
    <time_frame>12-week treament period</time_frame>
    <description>Nature and number of adverse event related to the use of the studied compression system (serious/ non-serious)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">178</enrollment>
  <condition>Venous Leg Ulcer</condition>
  <arm_group>
    <arm_group_label>URGO BD001</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with URGO DB001 during 12-week treament period (5 medical visits are planned: D0, W2, W4, W8, W12)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kit Biflex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with Kit Biflex during 12-week treament period (5 medical visits are planned: D0, W2, W4, W8, W12</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Venous compression system of the lower limbs stage C6 / C6r of the CEAP classification</intervention_name>
    <description>Etiological treatment of venous disease of the lower limbs stage C6 / C6r</description>
    <arm_group_label>Kit Biflex</arm_group_label>
    <arm_group_label>URGO BD001</arm_group_label>
    <other_name>Etiological treatment of venous disease of the lower limbs stage C6 / C6r</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient (≥ 18 years old), having given free, informed and written consent&#xD;
&#xD;
          -  Patient affiliated to a social security scheme&#xD;
&#xD;
          -  Patient agreeing to wear the study compression system daily&#xD;
&#xD;
          -  Patient with an ankle circumference between 18 and 25 cm&#xD;
&#xD;
          -  Target wound: stage C6 / C6r leg ulcer of the CEAP classification with a 0.8≤ ABPI≤1.3&#xD;
&#xD;
          -  Target wound with an area between 1 and 20 cm2&#xD;
&#xD;
          -  Target wound with age of ≤24 months&#xD;
&#xD;
        Criteria exclusion:&#xD;
&#xD;
          -  Patient with a systemic infection not controlled by appropriate antibiotic therapy&#xD;
&#xD;
          -  Patient having presented in the 3 months preceding his inclusion, a deep vein&#xD;
             thrombosis&#xD;
&#xD;
          -  Patient with advanced stage II or stage III lymphoedema&#xD;
&#xD;
          -  Patient bedridden or spending less than an hour per day standing&#xD;
&#xD;
          -  Clinically infected target wound&#xD;
&#xD;
          -  Cancerized target wound&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Dr SENET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires Paris Est (AP-HP) - Hopital TENON</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Dr SAUVADET, PhD</last_name>
    <phone>+33 6 71 19 78 91</phone>
    <email>a.sauvadet@fr.urgo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olivier Dr TACCA, PhD</last_name>
    <phone>+33 3 80 44 74 22</phone>
    <email>o.tacca@fr.urgo.com</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 29, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>compression system</keyword>
  <keyword>VLU</keyword>
  <keyword>mixed VLU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

